After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. After-hours trades for Takeda Pharmaceutical Company Limited (TAK) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.14, or -0.86%, to $16.17. The Takeda Pharmaceutical Company Limited has recorded 842 volume in the after hours trading session. Earlier, Yahoo Finance discussed this stock as it revealed Takeda Commits Over $30 Million in Five New Global CSR Partnerships To Further Drive Health Impact in 92 Countries.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Stocks Info
As a NYSE listed company, TAK falls under the Healthcare sector while operating within the Drug Manufacturers – Specialty & Generic industry segment. The current market capitalization of Takeda Pharmaceutical Company Limited is $51.53B. A total of 1.5 million shares were traded on the day, compared to an average of 2.15M shares.
Dividend
Investors prefer companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook. Takeda Pharmaceutical Company Limited pays an annual dividend of $0.97, resulting in a dividend yield of 5.95%, and it has a price to earnings (P/E) ratio of 25.05.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for TAK in the last 3 months, the mean price target is $16.36 with high estimates of $20.67 and low estimates of $12.80. In terms of 52-week highs and lows, TAK has a high of $17.15 and a low of $12.28.
As of this writing, TAK has an earnings estimate of $0 per share for the current quarter. EPS was calculated based on a consensus of 0 estimates, with a high estimate of $0 per share and a lower estimate of $0.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. TAK’s latest balance sheet shows that the firm has $875.00B in Cash & Short Term Investments as of fiscal 2022. There were $4.35T in debt and $2.15T in liabilities at the time. Its Book Value Per Share was $15.09, while its Total Shareholder’s Equity was $5.68T.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TAK is Buy with a score of 4.33.
